Adjuvant Taxanes in the Treatment of Breast Cancer: No Longer at the Tip of the Iceberg-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant Taxanes in the Treatment of Breast Cancer: No Longer at the Tip of the Iceberg

Published:2006-04 Issue:1 Volume:7 Page:51-58
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Dang Chau,Hudis Clifford

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Relation of positive axillary nodes to the prognosis of patients with primary breast cancer;Fisher;Cancer,1983

2. Update on the management of advanced breast cancer;Fornier;Oncology,1999

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005

4. National Institutes of Health Consensus Development Panel: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1, 2000;J Natl Cancer Inst Monogr,2001

5. Meeting highlights: international consensus on the primary therapy of early breast cancer 2005;Goldhirsch;Ann Oncol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Functional Role of Voltage-Gated Sodium Channel Nav1.5 in Metastatic Breast Cancer;Frontiers in Pharmacology;2020-07-23

2. Effects of EF-24, RAD001, and paclitaxel on the expression profiles of apoptotic and anti-apoptotic genes;Journal of Cancer Research and Therapeutics;2017

3. Sequential Dose-dense 5-fluorouracil, Epirubicin and Cyclophosphamide Followed by Docetaxel in Patients with Early Breast Cancer with Four or more Positive Lymph Nodes;Tumori Journal;2014-03

4. Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients;The Breast;2013-10

5. High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer;British Journal of Cancer;2011-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3